TP53 and ovarian carcinoma: In particular, a recent study describing the exogenous expression of DTX3a (confirmed by the sequence of the cited expression construct) in ovarian cancer cells with different TP53 status, found DTX3a to bear tumor suppressing activities in wild type bearing TP53 cells, while promoting cancer effects in TP53 mutant ovarian cancer cells [55].